Immunologic changes after house dust mite modified rush subcutaneous immunotherapy in allergic rhinitis children

• Main Authors: Tipyapa Rattanamanee, Putthapoom Lumjiaktase, Nanthisa Kemawichanura, Potjanee Kiewnga, Wanlapa Jotikasthira, Wiparat Manuyakorn
• Other Authors: Faculty of Medicine Ramathibodi Hospital, Mahidol University
• Format: Article
• Published: 2022
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/75088
• Institution: Mahidol University

Background: House dust mites (HDM) are the major causative allergen for allergic rhinitis. The sole disease-modifying therapy for allergic rhinitis is allergen immunotherapy (AIT). Rush immunotherapy is the accelerated build-up schedules to reach the target maintenance dose. Objective: To evaluate t...